<DOC>
	<DOC>NCT01131468</DOC>
	<brief_summary>The purpose of this study is to determine whether N-acetylcysteine is effective in the prevention of hearing loss in both ears due to aminoglycoside and/or vancomycine induced ototoxicity in peritoneal dialysis patients.</brief_summary>
	<brief_title>Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine</brief_title>
	<detailed_description />
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Endstage renal disease Undergoing continuous ambulatory peritoneal dialysis as a renal replacement therapy Clinical diagnosis of a peritonitis episode in a continuous ambulatory peritoneal dialysis patient Developing the first continuous ambulatory peritoneal dialysis related peritonitis episode Being treated with aminoglycoside antibiotics and vancomycine within the previous 3 months Detection of mechanical occlusion of external ear Having signs of disturbed integrity of tympanic membrane on otoscopy or tympanometry History of a continuous ambulatory peritoneal dialysis related peritonitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>ototoxicity</keyword>
	<keyword>aminoglycoside</keyword>
	<keyword>vancomycine</keyword>
	<keyword>peritoneal dialysis</keyword>
	<keyword>peritonitis</keyword>
</DOC>